[1]
N. . Nanava, S. . Metreveli, G. . Giorgobiani, T. . Chikovani, and N. . Janikashvili, “CD4+CD39+ cells in patients with hematologic malignancies”, GS, vol. 4, no. 5, pp. 22–32, Oct. 2022.